Understanding the variability in ultrafiltration obtained with icodextrin

Peritoneal Dialysis International

Volumn 29, Issue 4, 2009, Pages 407-411

  Lambie, Mark ^a,b   Stompor, Tomasz ^c   Davies, Simon ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^b KEELE UNIVERSITY   (United Kingdom)

^c JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMYLASE; DIALYSIS FLUID; FIBRINOGEN; GLUCOSE; ICODEXTRIN;

ALBUMIN BLOOD LEVEL; AMYLASE BLOOD LEVEL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; DIFFUSION; HUMAN; HYDRAULIC PERMEABILITY; HYDROSTATIC PRESSURE; METABOLISM; METABOLITE; NOTE; ONCOTIC PRESSURE; PRIORITY JOURNAL; ULTRAFILTRATION;

EID: 70349481265     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080902900406     Document Type: Note

References (22)

1. Mistry CD, Gokal R, Peers E. A randomized multicenter clinical trial comparing isosmolar icodextrin with hyperosmolar glucose solutions in CAPD. MIDAS Study Group. Multicenter Investigation of Icodextrin in Ambulatory Peritoneal Dialysis. Kidney Int 1994; 46:496-503.
2. Johnson DW, Arndt M, O'Shea A, Watt R, Hamilton J, Vincent K. Icodextrin as salvage therapy in peritoneal dialysis patients with refractory fluid overload. BMC Nephrol 2001; 2(1):2.
3. Wolfson M, Piraino B, Hamburger RJ, Morton AR. A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 2002; 40:1055-65.
4. Finkelstein F, Healy H, Abu-Alfa A, Ahmad S, Brown F, Gehr T, et al. Superiority of icodextrin compared with 4.25% dextrose for peritoneal ultrafiltration. J Am Soc Nephrol 2005; 16:546-54.
5. Woodrow G, Stables G, Oldroyd B, Gibson J, Turney JH, Brownjohn AM. Comparison of icodextrin and glucose solutions for the daytime dwell in automated peritoneal dialysis. Nephrol Dial Transplant 1999; 14:1530-5.
6. Jeloka TK, Ersoy FF, Yavuz M, Sahu KM, Camsari T, Utas C, et al. What is the optimal dwell time for maximizing ultrafiltration with icodextrin exchange in automated peritoneal dialysis patients? Perit Dial Int 2006; 26:336-40.
7. Venturoli D, Jeloka TK, Ersoy FF, Rippe B, Oreopoulos DG. The variability in ultrafiltration achieved with icodextrin, possibly explained. Perit Dial Int 2009; 29:415-21.
8. Jenkins SB, Wilkie ME. An exploratory study of a novel peritoneal combination dialysate (1.36% glucose/7.5% icodextrin), demonstrating improved ultrafiltration compared to either component studied alone. Perit Dial Int 2003; 23:475-80.
9. Freida P, Galach M, Filho JC, Werynski A, Lindholm B. Combination of crystalloid (glucose) and colloid (icodextrin) osmotic agents markedly enhances peritoneal fluid and solute transport during the long PD dwell. Perit Dial Int 2007; 27:267-76.
10. Parikova A, Smit W, Struijk DG, Krediet RT. Analysis of fluid transport pathways and their determinants in peritoneal dialysis patients with ultrafiltration failure. Kidney Int 2006; 70:1988-94. Epub 2006 Oct 11.
11. Williams JD, Craig KJ, Topley N, Williams GT. Peritoneal dialysis: changes to the structure of the peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl 2003; 84:158-61.
12. Wang T, Heimburger O, Cheng H, Waniewski J, Bergstrom J, Lindholm B. Effect of increased dialysate fill volume on peritoneal fluid and solute transport. Kidney Int 1997; 52: 1068-76.
13. Durand P, Chanliau J, Gamberoni J, Hestin D, Kessler M. Intraperitoneal hydrostatic pressure and ultrafiltration volume in CAPD. Adv Perit Dial 1993; 9:46-8.
14. Rusthoven E, van der Vlugt ME, van Lingen-van Bueren LJ, van Schaijk TC, Willems HL, Monnens LA, et al. Evaluation of intraperitoneal pressure and the effect of different osmotic agents on intraperitoneal pressure in children. Perit Dial Int 2005; 25:352-6.
15. Rusthoven E, Krediet RT, Willems HL, Monnens LA, Schroder CH. Peritoneal transport characteristics with glucose polymer-based dialysis fluid in children. J Am Soc Nephrol 2004; 15:2940-7.
16. Geranton F, Chantrel F, Bouiller M, Muller S, Kolb I, Moulin B, et al. Prediction of colloid osmotic pressure in renal patients. Clin Nephrol 2000; 53:269-75.
17. Duncan A, Young DS. Measurements of serum colloid osmotic pressure are of limited usefulness. Clin Chem 1982; 28:141-5.
18. Weisberg HF. Osmotic pressure of the serum proteins. Ann Clin Lab Sci 1978; 8:155-64.
19. Konings CJ, Kooman JP, Schonck M, Gladziwa U, Wirtz J, Van Den Wall Bake AW, et al. Effect of icodextrin on volume status, blood pressure and echocardiographic parameters: a randomized study. Kidney Int 2003; 63:1556-63.
20. Davies SJ, Garcia Lopez E, Woodrow G, Donovan K, Plum J, Williams P, et al. Longitudinal relationships between fluid status, inflammation, urine volume and plasma metabolites of icodextrin in patients randomized to glucose or icodextrin for the long exchange. Nephrol Dial Transplant 2008; 23:2982-8. Epub 2008 May 2.
21. Garcia-Lopez E, Werynski A, Heimburger O, Filho JC, Lindholm B, Anderstam B. Rate of synthetic oligosaccharide degradation as a novel measure of amylase activity in peritoneal dialysis patients. Perit Dial Int 2008; 28: 296-304.
22. Lam MF, Tse KC, Yip PS, Lui SL, Chan TM, Lo WK, et al. Retroperitoneal leakage as the cause for acute ultrafiltration failure and its associated risk factors in peritoneal dialysis. Perit Dial Int 2008; 28(Suppl 4):S7.